AAA Robert Lavine – Page 450

YuMe advertises itself successfully to Samsung

YuMe, the US-based TV 2.0 advertising technology company, secured $12m in funding on November 16th from Samsung Ventures, the corporate venturing unit belonging to electronics conglomerate Samsung, and venture capital (VC) firm Translink Capital. The investment made up part of a proposed $18m round YuMe, and takes YuMe’s overall funding to about $67.5m since its founding… Continue reading YuMe advertises itself successfully to Samsung

Groupon shares tumble post-IPO

Groupon’s share price plunged below its starting value on Wednesday less than three weeks after its initial public offering (IPO). Groupon’s share price was set at $20 per share pre-IPO, but began trading on Nasdaq on November 4th at $28 per share, rising to a peak of $31.14 per share on opening day, yet the… Continue reading Groupon shares tumble post-IPO

Unilever, Capvent target Asia

The Capvent Asia Consumption Co-investment Fund (CACC), a $150m fund co-run by consumer conglomerate Unilever and Switzerland-based fund of funds Capvent, has made its first close, according to venture capital website VCCircle. The amount secured for the first close is not known. The anchor investor in the fund will be Unilever’s corporate venturing unit, Unilever… Continue reading Unilever, Capvent target Asia

Mitsui helps iPlus drink $10m

China-based baby and childcare product company iPlus secured more than $10m in funding on Monday from Mitsui Global Investment, the growth investment division of Japan-based conglomerate Mitsui, and financial services firm the SBI Group, according to news provider PEdaily. Founded in 2006, iPlus deals in mother-and-baby products and services, and has built up a distribution… Continue reading Mitsui helps iPlus drink $10m

Pfizer’s interest in Excaliard beyond skin deep

Pharmaceutical conglomerate Pfizer acquired US-based biopharmaceutical company Excaliard yesterday for an undisclosed amount yesterday in a transaction expected to close before the end of the year. Excaliard’s only significant financing since its 2006 founding was a $15.5m series A round in November 2007,  by biomedical company Isis Pharmaceuticals and venture capital firms Alta Partners, ProQuest… Continue reading Pfizer’s interest in Excaliard beyond skin deep

Virgin and Strauss water the investment soil

UK-based conglomerate the Virgin Group and Strauss Water, the drinking water purification and filtration division of Israel-based food and beverage company the Strauss Group, embarked on a joint venture to provide customers with purified drinking water, on Sunday. The Virgin Green Fund, an independent private equity firm affiliated with the Virgin Group, will contribute $7.5m… Continue reading Virgin and Strauss water the investment soil